In general, methods to test the susceptibility of fungi to antifungal drugs require standardized techniques, but so far there is no methodology that is widely applicable to dermato- 
Introduction
The approval of protocols M27-A2 (CLSI 2002a) and M38-A (CLSI 2002b) , by the National Committee for Clinical Laboratory Standards (CLSI), motivated research on new methods for the standardization of susceptibility tests for yeasts and filamentous fungi. As an example, Meletiadis et al. (2002) have developed colorimetric and diffusion in agar methods. Protocol M27-A2 is specific for the determination of minimum inhibitory concentrations (MICs) for yeasts (Cryptococcus neoformans and Candida spp.), and protocol M38-A for filamentous, sporangiospore and conidium-forming fungi that cause invasive mycoses. Both protocols use the culture medium RPMI-1640 (without sodium bicarbonate and L-glutamine at pH 7.0) supplemented with 0.165 M morpholinepropanesulphonic acid (MOPS) and an incubation temperature of 35 C.
Inocula are 10 4 CFU ml À1 for Cryptococcus neoformans and 10 3 CFU ml À1 for Candida spp. The incubation period is of
24-48 h (document M27-A2) or up to 4 d (document M38-A).
Visual readings are performed in both cases. Cuenca-Estrella et al. 2002 , so far there are no methods to determine the MIC values of dermatophyte fungi that cause infections of the skin, hair and nail in humans and animals. Among these infections, onychomycosis are the most difficult to treat, affecting 20 % of the world population under 40-years old (Bradley et al. 1999) . These infections affect the nail bed causing dystrophy and sometimes result in complete nail loss (Roberts et al. 2003) . Although there are many antifungal drugs available that can be taken orally, only terbinafine, itraconazole and fluconazole are effective in the treatment of onychomycosis. Several topical antifungal preparations like amorolfine and tioconazole are available as nail lacquer or solution form. These topical antifungal drugs can be combined with oral therapy and achieve variable results, producing cure rates ranging from 20-70 % (Roberts et al. 2003; Marty et al. 2005) . Griseofulvin is an antifungal that has been used since 1959 for tinea capitis, and although it is not efficient in nail treatment, it is used for this purpose (Mock et al. 1998; Niewerth & Korting 2000) . Gupta & Shear (2000) , in an excellent review, discussed the percentage cure obtained by different investigators with these drugs using different treatments in patients with toenail onychomycosis. The aim of our work was to compare the MIC values of five oral antifungals (fluconazole, ketoconazole, itraconazole, terbinafine and griseofulvin) using two methodologies (document M38-A from CLSI and document used by AFST-EUCAST). One hundred samples of Trichophyton spp. (50 strains of T. mentagrophytes and 50 strains of T. rubrum), isolated from adult nails were tested. The following modifications were introduced in the protocols: RPMI-1640 media was supplemented with 2 % glucose at pH 7.0, buffered with MOPS 0.165 M, incubation period of 7 d, and temperature of 28 C, endpoints for fluconazole, itraconazole, ketoconazole and griseofulvin were set at 80 % growth inhibition and 100 % growth inhibition for terbinafine.
Materials and methods

Isolates
One hundred strains of Trichophyton mentagrophytes (50 strains) and T. rubrum (50 strains) isolated from different patients diagnosed with onchomycosis, were examined in this study. The clinical mycology laboratory, Mycoses Ltda., Belo Horizonte, Minas Gerais, Brazil, kindly donated these strains. Quality control isolates included T. mentagrophytes (ATCC 40004), T. rubrum (ATCC 40051), Candida parapsilosis (ATCC 22019), and Candida krusei (ATCC 6258). Isolates were cultured on MycoselÔ (Difco, Sparks, USA) for identification. The isolates were plated on Sabouraud dextrose agar (Difco) at 28 C and maintained as a suspension in sterile distilled water (Gupta & Kohli 2003 ) at 4 C (Pujol et al. 1996) until use.
Medium
Tests were performed in RPMI 1640 with L-glutamine, but without bicarbonate (Gibco BRL, Life technologies, Woerden,
The Netherlands), pH 7.0, supplemented with 2 % glucose, buffered with MOPS (FisherBiotech, New Jersey). The medium was sterilized by filtration.
Antifungal agents
Three azole derivatives were used in this study: fluconazole (Pfizer Sã o Paulo, Brazil), ketoconazole and itraconazole (Janssen-Cilag, Sã o José dos Campos, Sã o Paulo, Brazil). The allylamine terbinafine was obtained from Novartis (Sã o Paulo, Brazil) and griseofulvin from Schering-Plough (Rio de Janeiro, Brazil). All drugs were dissolved in 100 % dimethylsulfoxide (DMSO) (Gibco, Belo Horizonte, Minas Gerais, Brazil) following the CLSI protocol and were prepared as stock solutions of 1 mg ml
À1
. Serial two-fold dilutions were prepared according to document (M38-A) from the CLSI at 100 times the final concentration required, followed by further dilution (1:50) in RPMI 1640 to yield twice the final strength required for the test. The highest concentration of DMSO used in the tests corresponded to 1 % of the total volume and did not interfere with the growth of Trichophyton spp. studied.
Inocula preparation
Stock suspensions of dermatophytes were prepared from sporulating 7-d-old cultures grown on potato dextrose agar (Acumedia, Baltimore, USA) with 2 % in-house rice flour (Heinlaid et al. 2003; Jessup et al. 2000) at 28
C. Colonies were covered with 5 ml sterile distilled water and the surface scraped with a sterile loop. The mixture of conidia and hyphal fragments was filtered (Sartorius AG, Goettingen) through an 8 mm (Whatman 40, Sã o Paulo, Brazil) sterile filter and collected in a sterile tube. This procedure removed the majority of the hyphae, producing inocula composed mainly of spores (Petrikkou et al. 2001; Santos & Hamdan 2005; Santos et al. 2006) . Turbidity of the final inocula was adjusted to 0.5 Â 10 6 -5.0 Â 10 6 spores ml
À1
, at a wavelength of 520 nm, and transmission adjusted to 70 % in a spectrophotometer (Micronal B542, Sã o Paulo). Quantification was made by plating 0.01 ml of a 1:100 dilution of the adjusted inocula (varying between 0.5 to 2.5 Â 10 6 CFU ml
) on Sabouraud dextrose agar plates. Plates were incubated at 28 C and observed daily. Colonies were counted as soon as growth became visible. All inocula were adjusted to a final dilution recommended by both methodologies, in RPMI-1640 supplemented with 2 % glucose.
Test procedure
Tests were performed in sterile 96-well flat bottom polystyrene plates; 100 ml of each drug (in two-fold dilutions) were added to the plates that were then stored at À70 C until use. For the tests, 100 ml of diluted cell suspension was added to each well so that the final concentration was 0.5 Â 10 4 -5 Â 10 4 spores ml À1 for protocol M38-A (CLSI) and 0.5 Â 10 5 -5 Â 10 5 spores ml À1 for protocol AFST-EUCAST. For fluconazole, the concentrations were 64-0.125 mg ml
À1
, for ketoconazole and griseofulvin 8-0.015 mg ml
, for itraconazole 4-0.007 mg ml À1 and for terbinafine 4-0.007 mg ml
. Control wells (growth and sterility) were included for each assay performed alongside a duplicate series of drug dilutions. After 7 d at 28 C, plates were read visually (CLSI method) or with a spectrophotometer (AFST-EUCAST method). MICs were determined as the lowest concentration of drug that gave approximately 80 % inhibition (Ghannoum et al. 2004 ) of the growth control for fluconazole, ketoconazole, itraconazole and griseofulvin. For terbinafine, MICs were the lowest drug concentration that showed 100 % growth inhibition.
Data analysis
Determination of all MICs was repeated twice. Statistical analyses were performed with Wilcoxon (Mann-Whitney) and Kruskal-Wallis tests. P < 0.05 was considered significant.
Results
MIC values for 100 isolates of Trichophyton spp. are summarized in Tables 1 and 2 . Itraconazole and terbinafine had the highest inhibitory activities with both methodologies; 90 % of the isolates had MIC values of 0.25 mg ml À1 and 0.015 mg ml À1 , respectively (Table 2) . When the EUCAST method was used, seven isolates of T. mentagrophytes had MICs of 0.5 mg ml À1 for itraconazole and one had an MIC of 0.031 mg ml À1 for terbinafine (Table 1) .
For the drugs ketoconazole and griseofulvin, the MIC 90 values were the same using either methodology (1 mg ml À1 ; Table 2 ). Using the AFST-EUCAST method, one sample of T. mentagrophytes had a MIC of 4 mg ml À1 for griseofulvin and none of the T. rubrum isolates had MICs less than 0.5 mg ml
À1
. The same method detected five samples of T. mentagrophytes and 13 of T. rubrum with MICs of 2 mg ml À1 for the same drug (Table 2) . Fluconazole was the drug with the lowest activity against the isolates. Using both methods the same MIC 50 and MIC 90 values were observed ( Table 2 ). None of the T. mentagrophytes isolates were susceptible to 4 mg ml
, nevertheless five samples of T. rubrum were susceptible to 4 mg ml À1 when protocols M38-A of CLSI were used and eight samples of T. mentagrophytes had MICs !64 mg ml À1 when the AFST-EUCAST protocol was used (Table 1) . For all drugs tested, both methodologies gave similar MIC 50 values (Table 2 ). Table 3 shows that more than 92 % of the strains varied by less than three dilutions in both methods (CLSI and EUCAST). There was no significant difference (P < 0.05) between MIC values of both tested species with the two tested methods, considering no dilution interval.
Discussion
Currently, there are published data comparing the in vitro susceptibility of yeasts, especially Candida spp., using documents CLSI M27-A2, AFST-EUCAST and E-test (Chryssanthou & Cuenca-Estrella 2002; Cuenca-Estrella et al. 2002 Romero et al. 2004 ), but there is a scarcity of studies including dermatophytic fungi. In this study we compared two methods of microdilution in liquid media to determine the susceptibility of dermatophytes to antifungal drugs. Five drugs currently used in the treatment of dermatophytosis were tested (Mukherjee et al. 2003) . Korting et al. (1995) using the method described by Granade & Artis (1980) , reported an MIC 90 for griseofulvin of 10 mg ml À1 for T. mentagrophytes isolates and of 3 mg ml À1 for T. rubrum.
Here, we observed using both protocols (M38-A of CLSI and AFST-EUCAST) lower MIC 90 values of 1 mg ml À1 , for both species (Table 2) . They also obtained very high MIC values for fluconazole (1024 mg ml
À1
). In this study values obtained for fluconazole were MIC ! 64 mg ml
. An MIC 90 of 2 mg ml À1 was found for fluconazole against dermatophytes by both Jessup et al. (2000) and Ghannoum et al. (2004) , which is very different from the MIC found in the present study (MIC 90 ¼ 32 mg ml À1 ). This is possibly due to differences in the incubation period. In the case of terbinafine, very low values were observed by Korting et al. (MIC ¼ 0.05 mg ml
) and similar results were obtained in our study (0.015 mg ml À1 ). Our data, by using both methods, were similar to the ones obtained by Ferná ndez-Torres et al. (2000) , Ferná ndez-Torres et al. (2001) and Serrano-Martino et al. (2003) . MIC 50 values for ketoconazole and itraconazole varied by just for one dilution (plus or minus), while for terbinafine both methods were the same. Gupta & Kohli (2003) , working with 68 samples of T. rubrum and 14 of T. mentagrophytes and method M27-A (CLSI), found the MICs 90 for ketoconazole, itraconazole and terbinafine very similar to the ones reported here. Using a different method, and other species of dermatophytes such as Epidermophyton floccosum, Microsporum canis and Microsporum gypseum, Favre et al. (2003) also found the MIC 90 for fluconazole similar to the ones reported here, leading us to conclude that fluconazole should not chosen for the treatment of dermatophyte infections.
Overall, our data demonstrate the reproducibility of the methods employed to perform susceptibility tests in dermatophytes and confirm the in vitro inefficacy of fluconazole, as well as the excellent antifungal activity of terbinafine, and good activity of itraconazole. The methods suggested by the CLSI (document M38-A) and by the AFST-EUCAST can be considered very good protocols to determine MIC values in dermatophytes. Our modifications to adapt the susceptibility tests to this group of fungi did not affect the accuracy of the techniques when applied to this specific group. Moreover, the results we have obtained provide greater reproducibility and reliability of susceptibility/resistance 
